Oriel Therapeutics
Tarboro
About Oriel Therapeutics
Oriel Therapeutics is a specialty pharmaceutical company developing and commercializing products to improve respiratory care. Combining an experienced product development team and a growing portfolio of innovative drug delivery technologies, Oriel is focused on delivering compelling patient options for the treatment of asthma and COPD.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $26.5M
- Funding stage: M&A
- Last round: Series Unknown (Nov 2007)
- Website: orieltherapeutics.com
- Phone: +1 919-313-1290
Industries & Categories
Biotechnology, Medical Device, Pharmaceutical
Canonical: https://fsome.com/organization/oriel-therapeutics-1232414 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.